spot_img

Daily pill reduces HIV risk by 90%

Must Try

Trending

Nehanda Radio
Zimbabwe News and Internet Radio

UNITED KINGDOM – A daily pill can reduce the risk of getting HIV by almost 90 per cent, according to “game-changing” research that has prompted calls for the National Health Service (NHS) in the UK to make the drug available to gay men.

Daily pill reduces HIV risk by 90%
Daily pill reduces HIV risk by 90%

A report by The Times (UK) newspaper says that a study of British men showed that they were willing to take the pill, which did not appear to encourage unsafe sex.

- Advertisement -

Thousands could now be offered Truvada, which experts have likened to the contraceptive pill in giving people greater control over their sex lives. NHS chiefs are now deciding whether to offer the drug, which costs about £5,000 a year.

Campaigners since last year in October have been urging the NHS to act urgently to ensure the medication – which has been approved for use in the United States since 2012 – is offered to the most vulnerable groups as soon as possible.

Previous studies have found that if taken consistently Truvada can prevent infection in nine out of 10 cases – potentially saving the NHS millions of pounds each year in long-term treatment.

- Advertisement -

Last year 6,000 people were diagnosed with the condition – more than half of whom are gay or bisexual men. It is estimated that nearly 100,000 people in the UK are currently living with HIV with a fifth of those believed to be undiagnosed.

- Advertisement -

Related Articles

Zimbabwean comedian Boss Kedha, real name Rolland Lunga, famed for his skits with Bhutisi on P.O. Box TV (Picture via Facebook - Boss Kedha)

Zimbabwean comedian Boss Kedha encourages people to order a free HIV test

0
LONDON - Zimbabwean comedian Boss Kedha, real name Rolland Lunga, famed for his skits with Bhutisi on P.O. Box TV is encouraging people to order a free HIV test in England.
Lenacapavir is an antiretroviral medication used to treat and prevent HIV-1 infection. It works by inhibiting HIV's capsid protein, disrupting multiple steps in the virus's lifecycle, and can be administered as a long-acting subcutaneous injection given every six months, after an initial oral loading dose. (Picture by Olan Stock via DepositPhotos.com)

New long-acting HIV shot Lenacapavir gets rapid green light in Zimbabwe

0
HARARE - Zimbabwe has officially fast-tracked the approval of Lenacapavir, a pioneering long-acting HIV prevention drug, becoming one of the first countries in the region to authorise its use as a pre-exposure prophylaxis (PrEP) option.
Zimbabwe's Minister of Health and Child Care, Dr Douglas Mombeshora (Picture via X - icasa2025)

Zimbabwe records slight rise in HIV/AIDS deaths amidst funding concerns

0
HARARE - Zimbabwe has reported a marginal increase in HIV/AIDS-related deaths during the first half of 2025 compared to the same period in 2024, raising questions about the sustainability of the country's HIV response in the face of shifting donor funding.
US Secretary of State Marco Rubio (Picture via Gage Skidmore, CC BY-SA 3.0 , via Wikimedia Commons)

HIV patients in Zimbabwe breathe huge sigh of relief as US foreign aid resumes

15
HARARE - The United States government has lifted its halt on delivering HIV medicines and salaries for nurses in Zimbabwe, amidst a broader review of US foreign aid.
President Emmerson Mnangagwa during an interview on Carte Blanche in 2018 (Picture via YouTube - Carte Blanche)

ED urged to release prisoners after HIV transmission decriminalized

45
President Emmerson Mnangagwa has been urged to release prisoners locked up over HIV crimes after he recently signed a law that decriminalized HIV transmission. Before that any act of HIV transmission could result in a sentence of up to 20 years in prison.

Don't miss a story

Breaking News straight to your inbox.

No spam just news !

- Advertisement -spot_img
- Advertisement -spot_img
- Advertisement -spot_img

Latest Recipes

Latest

More Recipes Like This